Cargando…
Bone marrow-derived clonal mesenchymal stem cells inhibit ovalbumin-induced atopic dermatitis
Mesenchymal stem cells (MSCs) possess immunomodulatory activities, including suppression of T- and B-cell activation. However, their effects on atopic dermatitis (AD) have not yet been studied. Using an ovalbumin-induced AD mouse model, we investigated whether MSCs can be used as therapeutics in AD....
Autores principales: | Na, K, Yoo, H S, Zhang, Y X, Choi, M-S, Lee, K, Yi, T G, Song, S U, Jeon, M-S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123091/ https://www.ncbi.nlm.nih.gov/pubmed/25032868 http://dx.doi.org/10.1038/cddis.2014.299 |
Ejemplares similares
-
Systemic sensitization with the protein allergen ovalbumin augments local sensitization in atopic dermatitis
por: Yoo, Jane, et al.
Publicado: (2014) -
Beneficial effects of melittin on ovalbumin-induced atopic dermatitis in mouse
por: Kim, Woon-Hae, et al.
Publicado: (2017) -
Galectin-9 is Involved in Immunosuppression Mediated by Human Bone Marrow-derived Clonal Mesenchymal Stem Cells
por: Kim, Si-na, et al.
Publicado: (2015) -
Molecular Characterization of Neurally Differentiated Human Bone Marrow-derived Clonal Mesenchymal Stem Cells
por: Yi, TacGhee, et al.
Publicado: (2014) -
A Pilot Study To Establish an Ovalbumin-induced Atopic Dermatitis Minipig Model
por: Kim, Young Kyu, et al.
Publicado: (2021)